Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report)'s stock price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $19.33 and traded as high as $19.97. Getinge AB (publ) shares last traded at $19.78, with a volume of 3,300 shares.
Getinge AB (publ) Stock Performance
The company has a current ratio of 0.78, a quick ratio of 0.50 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $5.39 billion, a PE ratio of 34.72 and a beta of 1.10. The firm's 50-day simple moving average is $19.33 and its two-hundred day simple moving average is $18.82.
Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The company reported $0.20 EPS for the quarter. Getinge AB (publ) had a return on equity of 9.84% and a net margin of 4.71%. The firm had revenue of $779.56 million during the quarter.
Getinge AB (publ) Company Profile
(
Get Free Report)
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.
Featured Stories
Before you consider Getinge AB (publ), you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Getinge AB (publ) wasn't on the list.
While Getinge AB (publ) currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
